Location History:
- Alameda, CA (US) (2011)
- KC Wasenaar, NL (2011 - 2012)
- Leiden, NL (2021)
Company Filing History:
4 out of 98 
1 out of 1 Years Active: 2011-2021
Title: Frits R Rosendaal: Innovator in Genetic Research
Introduction
Frits R Rosendaal is a notable inventor based in KC Wassenaar, Netherlands. He has made significant contributions to the field of genetics, particularly in understanding venous thrombosis and coronary heart disease. With a total of four patents to his name, his work has implications for medical diagnostics and treatment.
Latest Patents
Rosendaal's latest patents focus on genetic polymorphisms associated with venous thrombosis. The first patent describes the discovery of genetic polymorphisms that are linked to venous thrombosis. This invention includes nucleic acid molecules containing these polymorphisms, variant proteins encoded by such molecules, and reagents for their detection. The second patent also addresses genetic polymorphisms related to coronary heart disease and their response to drug treatment. Similar to the first, it involves nucleic acid molecules, variant proteins, and methods for detection and use.
Career Highlights
Throughout his career, Frits R Rosendaal has worked with prominent organizations such as Celera Corporation and Leiden University Medical Center (LUMC). His research has significantly advanced the understanding of genetic factors in cardiovascular diseases.
Collaborations
Some of his notable coworkers include Lance Bare and James J Devlin. Their collaborative efforts have contributed to the success of Rosendaal's research initiatives.
Conclusion
Frits R Rosendaal's innovative work in genetic research has paved the way for advancements in medical diagnostics and treatment options for venous thrombosis and coronary heart disease. His contributions continue to impact the field significantly.